Editing Carmen Scheibenbogen

[[File:Carmen Scheibenbogen.png|200px|thumb|right|Source:Invest in ME]]
Professor Doctor '''Carmen Scheibenbogen''' is an Internal Medicine physician, [[ME/CFS]] doctor and the Professor for Immunology and Deputy Chair, Institute of Medical Immunology, at the University Hospital [[Charité Berlin|Charité]] in Berlin, Germany.  Her research focuses on the role of [[Epstein-Barr virus]] ([[EBV]]), particularly the characterization of [[EBV]] specific [[B cell]] and [[T cell]] response and the enhanced antibody response against [[EBV]] peptides in [[myalgic encephalomyelitis]] (ME) versus healthy controls.<ref>{{Cite web|url=http://investinme.org/cindex.shtml|title=Invest in ME Research - International ME Conferences and Colloquiums Home Page|website=investinme.org|access-date=2019-11-14}}</ref>

==Wirth-Scheibenbogen unifying hypothesis of ME/CFS ==
Between 2020 and 2021, with Prof. Dr [[Klaus Wirth]], Prof. Scheibenbogen published a set of articles describing a [[Wirth-Scheibenbogen hypothesis|detailed]] hypothesis of the pathophysiology of [[ME/CFS]].<ref name="Wirth2020a"/><ref name="Wirth2021a"/><ref name="Wirth2021b"/>

==EUROMENE==
Professor Scheibenbogen is the Leader of the [[Biomarkers]] Working Group of [[EUROMENE]], a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]].<ref>{{Cite web|url=https://www.cost.eu/actions/CA15111/|title=Action CA15111|website=COST|language=en-GB|access-date=2019-11-14}}</ref>  

==Diagnostic test==
Professor Scheibenbogen helped create the [[CellTrend Diagnostic Test]] which may help identify a subset of 20-30% of all patients with [[ME/CFS]]. These patients have elevated levels of three auto-antibodies, i.e., against the b2-adrenergic receptor, against the muscarinic cholinergic receptor 3 (M3) and against the muscarinic cholinergic receptor 4 (M4).<ref>{{Cite web|url=https://www.celltrend.de/en/pots-cfs-me-crps.html|title=POTS - CFS/ME - CRPS|website=CellTrend Luckenwalde|language=en-US|access-date=2020-02-18}}</ref>

==Awards==

*2016 [[Ramsay Award]] Program grant recipient, sponsored by the [[Solve ME/CFS Initiative]] for [[Autoimmunity |Autoimmune]] Signature in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]. This grant was shared with [[Madlen Löbel]], Charité Universitätsmedizin Berlin.<ref>{{Cite web|url=https://solvecfs.org/2016-ramsay-award-program-results/|title=2016 Ramsay Award Program Results|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-11-14}}</ref>
*2017 [[Ramsay Award]] Program grant was awarded to a team comprised of Dr. Carmen Scheibenbogen and Dr. [[Franziska Sotzny]] of Charité Universitätsmedizin Berlin, sponsored by the [[Solve ME/CFS Initiative]] for researching immunometabolism of [[T cell]]s and monocytes in [[ME/CFS]].<ref>{{Cite web|url=https://solvecfs.org/2017-ramsay-award-program-results/|title=2017 Ramsay Award Program Results|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-11-14}}</ref>

==Notable studies==

*2014, Deficient [[Epstein-Barr virus|EBV]]-Specific [[B cell|B-]] and [[T cell|T-Cell]] Response in Patients with Chronic Fatigue Syndrome<ref name="Loebel2014">{{Cite journal 
| last1   = Loebel               | first1 = Madlen              | authorlink1 = Madlen Loebel 
| last2   = Strohschein          | first2 = Kristin             | authorlink2 = 
| last3   = Giannini             | first3 = Carolin             | authorlink3 = 
| last4   = Koelsch              | first4 = Uwe                 | authorlink4 = 
| last5   = Bauer                | first5 = Sandra              | authorlink5 = 
| last6   = Doebis               | first6 = Cornelia            | authorlink6 = 
| last7   = Thomas               | first7 = Sybill              | authorlink7 = 
| last8   = Unterwalder          | first8 = Nadine              | authorlink8 = 
| last9   = von Baehr            | first9 = Volker              | authorlink9 = 
| last10  = Reinke               | first10 = Petra              | authorlink10 = 
| last11  = Knops                | first11 = Michael            | authorlink11 = 
| last12  = Hanitsch             | first12 = Leif G.            | authorlink12 = 
| last13  = Meisel               | first13 = Christian          | authorlink13 = 
| last14  = Volk                 | first14 = Hans-Dieter        | authorlink14 = 
| last15  = Scheibenbogen        | first15 = Carmen             | authorlink15 = Carmen Scheibenbogen
| title   = Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome | url = https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 
| journal = PLoS One    | volume = 9 | issue = 1   | page = e85387
| date    = Jan 15, 2014| pmid    = | doi     = 10.1371/journal.pone.0085387 }} </ref> -[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 (Full Text)]
*2015, Frequent [[IgG]] subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome<ref name="Guenther2015">{{Cite journal 
| last1   = Guenther         | first1 = Sabrina          | authorlink1 = 
| last2   = Loebel           | first2 = Madlen           | authorlink2 = Madlen Loebel 
| last3   = Mooslechner      | first3 = Agnes A          | authorlink3 = 
| last4   = Knops            | first4 = Michael          | authorlink4 = 
| last5   = Hanitsch         | first5 = Leif G           | authorlink5 = 
| last6   = Grabowski        | first6 = Patricia         | authorlink6 = Patricia Grabowski
| last7   = Wittke           | first7 = Kirsten          | authorlink7 = 
| last8   = Meisel           | first8 = Christian        | authorlink8 = 
| last9   = Unterwalder      | first9 = Nadine           | authorlink9 = 
| last10  = Volk             | first10 = Hans-Dieter     | authorlink10 = 
| last11  = Scheibenbogen    | first11 = Carmen          | authorlink11 = Carmen Scheibenbogen
| title   = Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome | url = https://www.sciencedirect.com/science/article/abs/pii/S0198885915004656
| journal = Human Immunology   | volume = 76   | issue = 10   | page = 729-35 | date    = 2015 
| doi     = 10.1016/j.humimm.2015.09.028}}</ref> - 
[https://www.sciencedirect.com/science/article/abs/pii/S0198885915004656 (Full Text)]
*2015, Polymorphism in [[COMT]] is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome<ref name="Loebel2015">{{Cite journal 
| last1   = Loebel           | first1 = Madlen          | authorlink1 = Madlen Loebel 
| last2   = Mooslechner      | first2 = Agnes Anna      | authorlink2 = 
| last3   = Bauer            | first3 = Sandra          | authorlink3 = 
| last4   = Günther          | first4 = Sabrina         | authorlink4 = 
| last5   = Letsch           | first5 = Anne            | authorlink5 = 
| last6   = Hanitsch         | first6 = Leif G          | authorlink6 = 
| last7   = Grabowski        | first7 = Patricia        | authorlink7 = Patricia Grabowski
| last8   = Meisel           | first8 = Christian       | authorlink8 =
| last9   = Volk             | first9 = Hans-Dieter     | authorlink9 = 
| last10  = Scheibenbogen    | first10 = Carmen         | authorlink10 = Carmen Scheibenbogen 
| title   = Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome | url = https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-015-0628-4
| journal = Journal of Translational Medicine    | volume = 13   | issue =     | page = 264 | date    = 2015 | pmc = PMC4536662 | pmid = 26272340
| doi     = 10.1186/s12967-015-0628-4 }} </ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-015-0628-4 (Full Text)]
*2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome<ref name="Loebel2016">{{Cite journal 
| last1   = Loebel            | first1 = M           | authorlink1 = Madlen Loebel 
| last2   = Grabowski         | first2 = P           | authorlink2 = Patricia Grabowski
| last3   = Heidecke          | first3 = H           | authorlink3 = 
| last4   = Bauer             | first4 = S           | authorlink4 = 
| last5   = Hanitsch          | first5 = LG          | authorlink5 = 
| last6   = Wittke            | first6 = K           | authorlink6 = 
| last7   = Meisel            | first7 = C           | authorlink7 = 
| last8   = Reinke            | first8 = P           | authorlink8 = 
| last9   = Volk              | first9 = H           | authorlink9 = 
| last10  = Fluge             | first10 = Ø          | authorlink10 = Øystein Fluge
| last11  = Mella             | first11 = O          | authorlink11 = Olav Mella
| last12  = Scheibenbogen     | first12 = C          | authorlink12 = Carmen Scheibenbogen
| title   = Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome | url = https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-015-0628-4
| journal = Brain, behavior, and immunity    | volume = 52   | issue =    | page = 32-39 | pmid = 26399744
| date    = 2016 
| doi     = 10.1016/j.bbi.2015.09.013}}</ref> - [https://www.sciencedirect.com/science/article/pii/S0889159115300209?via%3Dihub (Full Text)]
*2017, Serological profiling of the [[Epstein-Barr virus|EBV]] immune response in Chronic Fatigue Syndrome using a peptide microarray<ref name="Loebel2017">{{Cite journal 
| last1   = Loebel           | first1 = Madlen           | authorlink1 = Madlen Loebel 
| last2   = Eckey            | first2 = Maren            | authorlink2 = 
| last3   = Sotzny           | first3 = Franziska        | authorlink3 = Franziska Sotzny
| last4   = Hahn             | first4 = Elisabeth        | authorlink4 = 
| last5   = Bauer            | first5 = Sandra           | authorlink5 = 
| last6   = Grabowski        | first6 = Patricia         | authorlink6 = Patricia Grabowski
| last7   = Zerweck          | first7 = Johannes         | authorlink7 = 
| last8   = Holenya          | first8 = Pavlo            | authorlink8 = 
| last9   = Hanitsch         | first9 = Leif G.          | authorlink9 = 
| last10  = Wittke           | first10 = Kirsten         | authorlink10 = 
| last11  = Borchmann        | first11 = Peter           | authorlink11 = 
| last12  = Rüffer           | first12 = Jens-Ulrich     | authorlink12 = 
| last13  = Hiepe            | first13 = Falk            | authorlink13 = 
| last14  = Ruprecht         | first14 = Klemens         | authorlink14 = 
| last15  = Behrends         | first15 = Uta             | authorlink15 = 
| last16  = Meindl           | first16 = Carola          | authorlink16 = 
| last17  = Volk             | first17 = Hans-Dieter     | authorlink17= 
| last18  = Reimer           | first18 = Ulf             | authorlink18 = 
| last19  = Scheibenbogen    | first19 = Carmen          | authorlink19 = Carmen Scheibenbogen
| title   = Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray | url = https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0179124
| journal = PLOS ONE    | volume = 12   | issue = 6   | page = e0179124| date    = 2017 | doi     = 10.1371/journal.pone.0179124 }}</ref> - [https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0179124 (Full Text)]
*2017, The European ME/CFS [[Biomarker]] Landscape project: an initiative of the European network EUROMENE<ref name="EUROMENE2017">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Blanco|first3=Julià|author-link3=Julià Blanco|last4=Capelli|first4=Enrica|author-link4=Enrica Capelli|last5=Lacerda|first5=Eliana|author-link5=Eliana Lacerda|last6=Authier|first6=Jerome|author-link6=François Jérôme Authier|last7=Meeus|first7=Mira|author-link7=Mira Meeus|last8=Castro Marrero|first8=Jesus|author-link8=Jesús Castro-Marrero|last9=Nora-Krukle|first9=Zaiga|author-link9=Zaiga Nora-Krukle|last10=Oltra|first10=Elisa|author-link10=Elisa Oltra|last11= Strand|first11=Elin Bolle|author-link11=Elin Bolle Strand|last12= Shikova|first12= Evelina|author-link12= Evelina Shikova|last13= Sekulic|first13=Slobodan|author-link13=Slobodan Sekulic|last14=Murovska|first14=Modra|author-link14=Modra Murovska|date=2017-07-26|title=The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1263-z|journal=Journal of Translational Medicine|language=en|volume=15|issue=1|pages=|doi=10.1186/s12967-017-1263-z|issn=1479-5876|pmc=5530475|pmid=28747192|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530475/ (Full Text)]
*2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an [[autoimmune disease]]<ref name="Sotzny2018">{{Cite journal 
| last1   = Sotzny           | first1 = Franziska       | authorlink1 = Franziska Sotzny
| last2   = Blanco           | first2 = Julià           | authorlink2 = Julià Blanco
| last3   = Capelli          | first3 = Enrica          | authorlink3 = Enrica Capelli
| last4   = Castro-Marrero   | first4 = Jesús           | authorlink4 = Jesús Castro-Marrero
| last5   = Steiner          | first5 = Sophie          | authorlink5 = 
| last6   = Murovska         | first6 = Modra           | authorlink6 = Modra Murovska 
| last7   = Scheibenbogen    | first7 = Carmen          | authorlink7 = Carmen Scheibenbogen
| title   = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease | url = https://www.sciencedirect.com/science/article/pii/S1568997218300880
| journal = Autoimmunity Reviews    | volume =  17  | issue = 6   | page = 601-609
| date    = 2018| pmid    = 29635081 | doi     = 10.1016/j.autrev.2018.01.009 }} </ref> - [https://www.sciencedirect.com/science/article/pii/S1568997218300880 (Full Text)]
*2018, [[Immunoadsorption]] to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME<ref name="Immunoadsorption2018">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Loebel|first2=Madlen|author-link2=Madlen Löbel|last3=Freitag|first3=Helma|author-link3=Helma Freitag|last4=Krueger|first4=Anne|last5=Bauer|first5=Sandra|author-link5=Sandra Bauer|last6=Antelmann|first6=Michaela|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Heidecke|first9=Harald|last10=Reinke|first10=Petra|last11=Volk|first11=Hans-Dieter|last12=Grabowski|first12=Patricia|author-link12=Patricia Grabowski|date=2018|title=Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672|journal=PLoS ONE|volume=13|issue=3|pages=e0193672|doi=10.1371/journal.pone.0193672|via=}}</ref> - [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672 (Full Text)]
*2018, The expression signature of very long non-coding [[RNA]] in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Yang2018">{{Cite journal|last=Yang|first=Chin-An|last2=Bauer|first2=Sandra|author-link2=Sandra Bauer|last3=Ho|first3=Yu-Chen|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Chang|first5=Jan-Gowth|last6=Scheibenbogen|first6=Carmen|author-link6=Carmen Scheibenbogen|date=2018-08-17|title=The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1600-x|journal=Journal of Translational Medicine|language=en|volume=16|issue=|pages=231|doi=10.1186/s12967-018-1600-x|issn=1479-5876|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1600-x (Full Text)]
* 2018, Prevalence and incidence of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] in Europe—the Euro-epiME study from the European network [[EUROMENE]]: a protocol for a systematic review<ref name="Lopez2018">{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Castro-Marrero|first2=Jesus|author-link2=Jesús Castro-Marrero|last3=Wang|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=Andrejs Ivanovs|last6=Nacul|first6=Luis|author-link6=Luis Nacul|last7=Sepúlveda|first7=Nuno|author-link7=Nuno Sepulveda|last8=Strand|first8=Elin B.|author-link8=Elin Strand|last9=Pheby|first9=Derek|author-link9=Derek Pheby|last10=Alegre|first10=José|author-link10=José Alegre|last11=Scheibenbogen|first11=Carmen|author-link11=Carmen Scheibenbogen|last12=Shikova|first12=Evelina|author-link12=Evelina Shikova|last13=Lorusso|first13=Lorenzo|author-link13=Lorenzo Lorusso|last14=Capelli|first14=Enrica|author-link14=Enrica Capelli|last15=Sekulic|first15=Slobodan|author-link15=Slobodan Sekulic|last16=Lacerda|first16=Eliana|author-link16=Eliana Lacerda|last17=Murovska|first17=Modra|author-link17=Modra Murovska|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmc=|pmid=30181183|via=}}</ref> - [https://bmjopen.bmj.com/content/8/9/e020817 (Full text)]
*2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)<ref name="Rasa2018">{{Cite journal|last=Rasa|first=Santa|author-link=Santa Rasa|last2=Nora-Krukle|first2=Zaiga|author-link2=Zaiga Nora-Krukle|last3=Henning|first3=Nina|author-link3=|last4=Eliassen|first4=Eva|author-link4=|last5=Shikova|first5=Evelina|author-link5=Evelina Shikova|last6=Harrer|first6=Thomas|author-link6=Thomas Harrer|last7=Scheibenbogen|first7=Carmen|author-link7=Carmen Scheibenbogen|last8=Murovska|first8=Modra|author-link8=Modra Murovska|last9=Prusty|first9=Bhupesh K.|author-link9=Bhupesh Prusty|last10=European Network on ME/CFS (EUROMENE)|first10=|author-link10=EUROMENE|date=2018-10-01|title=Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y|journal=Journal of Translational Medicine|language=en|volume=16|issue=1|pages=|doi=10.1186/s12967-018-1644-y|issn=1479-5876|pmc=|pmid=30285773|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1644-y (Full text)]
*2020, IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS<ref name="IgG2020">{{Cite journal|last=Hartwig|first=Jelka|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Bauer|first3=Sandra|author-link3=Sandra Bauer|last4=Heidecke|first4=Harald|last5=Riemekasten|first5=Gabriela|last6=Dragun|first6=Duska|last7=Meisel|first7=Christian|last8=Dames|first8=Claudia|last9=Grabowski|first9=Patricia|author-link9=Patricia Grabowski|last10=Scheibenbogen|first10=Carmen|date=2020-03-01|title=IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS|url=http://www.sciencedirect.com/science/article/pii/S2666354620300120|journal=Brain, Behavior, & Immunity - Health|language=en|volume=3|pages=100047|doi=10.1016/j.bbih.2020.100047|issn=2666-3546}}</ref> - [https://www.sciencedirect.com/science/article/pii/S2666354620300120 (Full text)]
*2020, Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Schreiner2020">{{Cite journal|last=Schreiner|first=Philipp|author-link=|last2=Harrer|first2=Thomas|author-link2=Thomas Harrer|last3=Scheibenbogen|first3=Carmen|author-link3=Carmen Scheibenbogen|last4=Lamer|first4=Stephanie|author-link4=|last5=Schlosser|first5=Andreas|author-link5=|last6=Naviaux|first6=Robert K.|author-link6=Robert Naviaux|last7=Prusty|first7=Bhupesh K.|author-link7=Bhupesh Prusty|date=2020-04-01|title=Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.immunohorizons.org/content/4/4/201|journal=ImmunoHorizons|language=en|volume=4|issue=4|pages=201–215|doi=10.4049/immunohorizons.2000006|issn=2573-7732|pmc=|pmid=32327453|access-date=|quote=|via=}}</ref> - [https://www.immunohorizons.org/content/4/4/201 (Full text)]
* 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology<ref name="Estevez-Lopez2020">{{Cite journal|last=Estévez-López|first=Fernando|author-link=Fernando Estévez-López|last2=Mudie|first2=Kathleen|author-link2=|last3=Wang-Steverding|first3=Xia|author-link3=Xia Wang-Steverding|last4=Bakken|first4=Inger Johanne|author-link4=Inger Johanne Bakken|last5=Ivanovs|first5=Andrejs|author-link5=|last6=Castro-Marrero|first6=Jesús|author-link6=Jesús Castro-Marrero|last7=Nacul|first7=Luis|author-link7=Luis Nacul|last8=Alegre|first8=Jose|author-link8=José Alegre|last9=Zalewski|first9=Paweł|last10=Słomko|first10=Joanna|author-link10=|last11=Bolle Strand|first11=Elin|author-link11=Elin Bolle Strand|last12=Pheby|first12=Derek|author-link12=Derek Pheby|last13=Shikova|first13=Evelina|author-link13=Evelina Shikova|last14=Lorusso|first14=Lorenzo|author-link14=Lorenzo Lorusso|last15=Capelli|first15=Enrica|author-link15=Enrica Capelli|last16=Sekulic|first16=Slobodan|author-link16=Slobodan Sekulic|last17=Scheibenbogen|first17=Carmen|author-link17=Carmen Scheibenbogen|last18=Sepúlveda|first18=Nuno|author-link18=Nuno Sepúlveda|last19=Murovska|first19=Modra|author-link19=Modra Murovska|last20=Lacerda|first20=Eliana|authorlink20=Eliana Lacerda|others=(EUROMENE)|date=May 2020|title=Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology|url=https://www.mdpi.com/2077-0383/9/5/1557|journal=Journal of Clinical Medicine|language=en|volume=9|issue=5|pages=1557|doi=10.3390/jcm9051557|pmc=|pmid=|quote=|access-date=|via=}}</ref> - [https://www.mdpi.com/2077-0383/9/5/1557/htm (Full text)]
* 2020, Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="endothelial2020">{{Cite journal|last=Scherbakov|first=Nadja|author-link=|last2=Szklarski|first2=Marvin|author-link2=|last3=Hartwig|first3=Jelka|author-link3=|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Lorenz|first5=Sebastian|author-link5=|last6=Meyer|first6=Antje|author-link6=|last7=Grabowski|first7=Patricia|author-link7=Patricia Grabowski|last8=Doehner|first8=Wolfram|last9=Scheibenbogen|first9=Carmen|author-link9=Carmen Scheibenbogen|date=2020|title=Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12633|journal=ESC Heart Failure|language=en|volume=7|issue=3|pages=1064–1071|doi=10.1002/ehf2.12633|issn=2055-5822|pmc = 7261521|pmid=32154656|access-date=|quote=|via=}}</ref> - [https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12633 (Full text)]
*2020, Autoimmunity-Related Risk Variants in [[PTPN22]] and [[CTLA4]] Are Associated With ME/CFS With Infectious Onset<ref name="Steiner2021">{{Cite journal|last=Steiner|first=Sophie|last2=Becker|first2=Sonya C.|last3=Hartwig|first3=Jelka|last4=Sotzny|first4=Franziska|last5=Lorenz|first5=Sebastian|last6=Bauer|first6=Sandra|author-link6=Sandra Bauer|last7=Löbel|first7=Madlen|last8=Stittrich|first8=Anna B.|last9=Grabowski|first9=Patricia|author-link9=Patricia Grabowski|last10=Scheibenbogen|first10=Carmen|date=2020|title=Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset|url=https://www.frontiersin.org/article/10.3389/fimmu.2020.00578|journal=Frontiers in Immunology|volume=11|pages=578|doi=10.3389/fimmu.2020.00578|issn=1664-3224}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2020.00578/full (Full text)]
*2020, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption<ref name="Tolle2020">{{Cite journal|last=Tölle|first=Markus|author-link=Markus Tölle|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Antelmann|first3=Michaela|last4=Hartwig|first4=Jelka|last5=Schuchardt|first5=Mirjam|last6=van der Giet|first6=Markus|last7=Eckardt|first7=Kai-Uwe|last8=Grabowski|first8=Patricia|author-link8=Patricia Grabowski|last9=Scheibenbogen|first9=Carmen|author-link9=Carmen Scheibenbogen|date=2020-07-30|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption|url=https://www.mdpi.com/2077-0383/9/8/2443|journal=Journal of Clinical Medicine|language=en|volume=9|issue=8|pages=2443|doi=10.3390/jcm9082443|issn=2077-0383|pmc=PMC7465279|pmid=32751659}}</ref> - [https://doi.org/10.3390/jcm9082443 (Full text)]
*2020, A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors<ref name="Wirth2020a">{{Cite journal|last=Wirth|first=Klaus|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen|date=2020-06-01|title=A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors|url=https://www.sciencedirect.com/science/article/pii/S1568997220300823|journal=Autoimmunity Reviews|language=en|volume=19|issue=6|pages=102527|doi=10.1016/j.autrev.2020.102527|issn=1568-9972}}</ref> - [https://doi.org/10.1016/j.autrev.2020.102527 (Full text)]
*2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts<ref name="Bynke2020">{{Cite journal|last=Bynke|first=Annie|author-link=|last2=Julin|first2=Per|author-link2=|last3=Gottfries|first3=Carl-Gerhard|author-link3=Carl-Gerhard Gottfries|last4=Heidecke|first4=Harald|author-link4=|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Bergquist|first6=Jonas|author-link6=Jonas Bergquist|date=Aug 2020|title=Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474431|journal=Brain, Behavior, & Immunity - Health|volume=7|issue=|pages=100107|doi=10.1016/j.bbih.2020.100107|issn=2666-3546|pmc=8474431|pmid=34589868|access-date=|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474431 (Full text)]
*2021, Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref name="Wirth2021a">{{Cite journal|last=Wirth|first=Klaus J.|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen |date=2021-04-21|title=Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|url=https://doi.org/10.1186/s12967-021-02833-2|journal=Journal of Translational Medicine|volume=19|issue=1|pages=162|doi=10.1186/s12967-021-02833-2|issn=1479-5876|pmc=PMC8058748|pmid=33882940}}</ref> - [https://doi.org/10.1186/s12967-021-02833-2 (Full text)]
* 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies<ref name="Malato2021">{{Cite journal|last=Malato|first=João|author-link=|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Bauer|first3=Sandra|author-link3=Sandra Bauer|last4=Freitag|first4=Helma|author-link4=Helma Freitag|last5=Fonseca|first5=André|author-link5=|last6=Grabowska|first6=Anna D|author-link6=|last7=Graça|first7=Luís|last8=Cordeiro|first8=Clara|last9=Nacul|first9=Luís|author-link9=Luis Nacul|last10=Lacerda|first10=Eliana M|author-link10=Eliana Lacerda|last11=Castro-Marrero|first11=Jesus|author-link11=Jesus Castro-Marrero|last12=Scheibenbogen|first12=Carmen|author-link12=Carmen Scheibenbogen|last13=Westermeier|first13=Francisco|author-link13=|last14=Sepúlveda|first14=Nuno|author-link14=Nuno Sepúlveda|date=2021-03-24|title=The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies|url=http://medrxiv.org/lookup/doi/10.1101/2021.03.23.21254175|journal=medRxiv|language=en|volume=|issue=|pages=|doi=10.1101/2021.03.23.21254175|pmc=|pmid=33791744|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010776/ (Full text)]
*2021, European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe<ref name="Nacul2021">{{Cite journal|last=Nacul|first=Luis|author-link=Luis Nacul|last2=Authier|first2=François Jérôme|author-link2=François Jérôme Authier|last3=Scheibenbogen|first3=Carmen|author-link3=Carmen Scheibenbogen|last4=Lorusso|first4=Lorenzo|author-link4=Lorenzo Lorusso|last5=Helland|first5=Ingrid Bergliot|author-link5=|last6=Martin|first6=Jose Alegre|author-link6=José Alegre|last7=Sirbu|first7=Carmen Adella|last8=Mengshoel|first8=Anne Marit|last9=Polo|first9=Olli
|first10=Uta|last10=Behrends|author-link10=Uta Behrends
|first11=Henrik|last11=Nielsen
|first12=Patricia|last12=Grabowski|author-link12=Patricia Grabowski
|first13=Slobodan|last13=Sekulic
|first14=Nuno|last14=Sepulveda
|first15=Fernando|last15=Estévez-López
|first16=Pawel|last16=Zalewski
|first17=Derek F. H.|last17=Pheby|author-link17=Derek Pheby
|first18=Jesus|last18=Castro-Marrero|author-link18=Jesus Castro-Marrero
|first19=Giorgos K.|last19=Sakkas
|first20=Enrica|last20=Capelli
|first21=Ivan|last21=Brundsdlund
|first22=John|last22=Cullinan
|first23=Angelika|last23=Krumina
|first24=Jonas|last24=Bergquist|authorlink24=Jonas Bergquist
|first25=Modra|last25=Murovska
|first26=Ruud C. W.|last26=Vermuelen|authorlink26=Ruud Vermuelen
|first27=Eliana M.|last27=Lacerda|authorlink27=Eliana Lacerda|others=(EUROMENE)|date=May 2021|title=European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161074|journal=Medicina|language=en|volume=57|issue=5|pages=510|doi=10.3390/medicina57050510|pmc=PMC8161074|pmid=34069603|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161074 (Full text)]
*2021, Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Freitag2021">{{Cite journal|last=Freitag|first=Helma|author-link=Helma Freitag|last2=Szklarski|first2=Marvin|author-link2=|last3=Lorenz|first3=Sebastian|author-link3=|last4=Sotzny|first4=Franziska|author-link4=Franziska Sotzny|last5=Bauer|first5=Sandra|author-link5=Sandra Bauer|last6=Philippe|first6=Aurélie|author-link6=|last7=Kedor|first7=Claudia|last8=Grabowski|first8=Patricia|author-link8=Patricia Grabowski|last9=Lange|first9=Tanja|last10=Riemekasten|first10=Gabriela|last11=Heidecke|first11=Harald|last12=Scheibenbogen|first12=Carmen|author-link12=Carmen Scheibenbogen|date=Jan 2021|title=Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397061/|journal=Journal of Clinical Medicine|language=en|volume=10|issue=16|pages=3675|doi=10.3390/jcm10163675|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397061/ (Full text)]
*2021, Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study<ref name="Scheibenbogen2021a">{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Sotzny|first2=Franziska|author-link2=Franziska Sotzny|last3=Hartwig|first3=Jelka|author-link3=|last4=Bauer|first4=Sandra|author-link4=Sandra Bauer|last5=Freitag|first5=Helma|author-link5=Helma Freitag|last6=Wittke|first6=Kirsten|author-link6=|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Loebel|first9=Madlen|last10=Grabowski|first10=Patricia Grabowski|author-link10=Patricia Grabowski|date=Jan 2021|title=Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198960/|journal=Journal of Clinical Medicine|language=en|volume=10|issue=11|pages=2420|doi=10.3390/jcm10112420|pmc=PMC8198960|pmid=34072494|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198960/ (Full text)]
*2021, Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany<ref name="Froehlich2021">{{Cite journal|last=Froehlich|first=Laura|author-link=|last2=Hattesohl|first2=Daniel B. R.|author-link2=|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|last4=Scheibenbogen|first4=Carmen|author-link4=Carmen Scheibenbogen|last5=Behrends|first5=Uta|author-link5=Uta Behrends|last6=Thoma|first6=Manuel|author-link6=|date=Jul 2021|title=Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306083/|journal=Medicina|language=en|volume=57|issue=7|pages=646|doi=10.3390/medicina57070646|pmc=PMC8306083|pmid=34201825|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306083/ (Full text)]
*2021, An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Wirth2021b">{{Cite journal|last=Wirth|first=Klaus J.|author-link=Klaus Wirth|last2=Scheibenbogen|first2=Carmen|author-link2=Carmen Scheibenbogen|last3=Paul|first3=Friedemann|author-link3=|date=2021-11-22|title=An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03143-3|journal=Journal of Translational Medicine|volume=19|issue=1|pages=471|doi=10.1186/s12967-021-03143-3|issn=1479-5876|pmc=PMC8607226|pmid=34809664|access-date=|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03143-3 (Full text)]
*2021, S1 Guideline Post-COVID/Long-COVID<ref name="Koczulla2021">{{Cite journal|last=Koczulla|first=Andreas Rembert|author-link=|last2=Ankermann|first2=Tobias|author-link2=|last3=Behrends|first3=Uta|author-link3=Uta Behrends|last4=Berlit|first4=Peter|author-link4=|last5=Böing|first5=Sebastian|author-link5=|last6=Brinkmann|first6=Folke|author-link6=|last7=Franke|first7=Christian|last8=Glöckl|first8=Rainer|last9=Gogoll|first9=Christian
|last10=Hummel|first10=Thomas|last11=Kronsbein|first11=Juliane|last12=Maibaum|first12=Thomas|last13=Peters|first13=Eva M. J.
|last14=Pfeifer|first14=Michael|last15=Platz|first15=Thomas|last16=Pletz|first16=Matthias|last17=Pongratz|first17=Georg
|last18=Powitz|first18=Frank|last19=Rabe|first19=Klaus F.|last20=Scheibenbogen|first20=Carmen|authorlink20=Carmen Scheibenbogen|last21=Stallmach|first21=Andreas|last22=Stegbauer|first22=Michael|last23=Wagner|first23=Hans Otto|last24=Waller|first24=Christiane|last25=Wirtz|first25=Hubert|last26=Zeiher|first26=Andreas|last27=Zwick|first27=Ralf Harun
|date=Nov 2021|title=S1-Leitlinie Post-COVID/Long-COVID|trans-title=S1 Guideline Post-COVID/Long-COVID|url=http://www.thieme-connect.de/DOI/DOI?10.1055/a-1551-9734|journal=Pneumologie|language=de|volume=75|issue=11|pages=869–900|doi=10.1055/a-1551-9734|issn=0934-8387|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.thieme-connect.com/DOI/DOI?10.1055/a-1551-9734 (Full text, in German)]
*2021, Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome<ref name="Froehlich2020">{{Cite journal|last=Froehlich|first=Laura|author-link=|last2=Hattesohl|first2=Daniel Br|author-link2=|last3=Cotler|first3=Joseph|author-link3=|last4=Jason|first4=Leonard A.|author-link4=Leonard Jason|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Behrends|first6=Uta|author-link6=Uta Behrends|date=2021-07-09|title=Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome|url=https://journals.sagepub.com/doi/10.1177/13591053211027631?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed|journal=Journal of Health Psychology|volume=|issue=|pages=13591053211027631|doi=10.1177/13591053211027631|issn=1461-7277|pmc=|pmid=34240650|access-date=|quote=|via=}}</ref> - [https://journals.sagepub.com/doi/10.1177/13591053211027631?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed (Full text)]
*2021, Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank<ref name="Domingues2021">{{Cite journal|last=Domingues|first=Tiago Dias|author-link=|last2=Grabowska|first2=Anna D.|author-link2=|last3=Lee|first3=Ji-Sook|author-link3=|last4=Ameijeiras-Alonso|first4=Jose|author-link4=|last5=Westermeier|first5=Francisco|author-link5=|last6=Scheibenbogen|first6=Carmen|author-link6=Carmen Scheibenbogen|last7=Cliff|first7=Jacqueline M.|author-link7=Jacqueline Cliff|last8=Nacul|first8=Luis|author-link8=Luis Nacul|last9=Lacerda|first9=Eliana M.|author-link9=Eliana Lacerda|last10=Mouriño|first10=Helena|last11=Sepúlveda|first11=Nuno|date=2021|title=Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287507/|journal=Frontiers in Medicine|volume=8|issue=|pages=686736|doi=10.3389/fmed.2021.686736|issn=2296-858X|pmc=8287507|pmid=34291062|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287507/ (Full text)]
*2021, Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS<ref name="Jakel2021">{{Cite journal|last=Jäkel|first=Bianka|author-link=|last2=Kedor|first2=Claudia|author-link2=|last3=Grabowski|first3=Patricia|author-link3=Patricia Grabowski|last4=Wittke|first4=Kirsten|author-link4=|last5=Thiel|first5=Silvia|author-link5=|last6=Scherbakov|first6=Nadja|author-link6=|last7=Doehner|first7=Wolfram|last8=Scheibenbogen|first8=Carmen|author-link8=Carmen Scheibenbogen|last9=Freitag|first9=Helma|author-link9=Helma Freitag|date=2021-04-19|title=Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056497/|journal=Journal of Translational Medicine|volume=19|issue=1|pages=159|doi=10.1186/s12967-021-02774-w|issn=1479-5876|pmc=8056497|pmid=33874961|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056497/ (Full text)]
*2021, Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Szklarski2021">{{Cite journal|last=Szklarski|first=Marvin|author-link=|last2=Freitag|first2=Helma|author-link2=Helma Freitag|last3=Lorenz|first3=Sebastian|author-link3=|last4=Becker|first4=Sonya C.|author-link4=|last5=Sotzny|first5=Franziska|author-link5=Franziska Sotzny|last6=Bauer|first6=Sandra|author-link6=Sandra Bauer|last7=Hartwig|first7=Jelka|last8=Heidecke|first8=Harald|last9=Wittke|first9=Kirsten|last10=Kedor|first10=Claudia|last11=Hanitsch|first11=Leif G.|last12=Grabowski|first12=Patricia|authorlink12=Patricia Grabowski|last13=Sepúlveda|first13=Nuno|last14=Scheibenbogen|first14=Carmen|authorlink14=Carmen Scheibenbogen|date=2021|title=Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056217/|journal=Frontiers in Immunology|volume=12|issue=|pages=644548|doi=10.3389/fimmu.2021.644548|issn=1664-3224|pmc=8056217|pmid=33889154|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056217/ (Full text)]

==Clinic location==

*[[Charité Berlin|Charité]] University Medicine, Berlin, Germany

==Talks and interviews==
*2021, [https://meassociation.org.uk/2021/09/iacfs-me-conference-professor-carmen-scheibenbogen-emerging-treatment-options-for-autoimmune-me-cfs/ Autoimmune ME/CFS Treatment Options] - IACFS/ME Conference
*2018, [https://cfc.charite.de/#c30485288 Talk "Chronic Fatigue Syndrome" for General Practitioners] 
*2014, Speaker at the 9th [[Invest in ME International ME Conference]] [http://www.investinme.org/IIMEC9.shtml#dvd DVD available]

==Online presence==
*[https://www.researchgate.net/profile/Carmen-Scheibenbogen Researchgate.net]
*[http://www.ncbi.nlm.nih.gov/pubmed/?term=Scheibenbogen%20C%5BAuthor%5D&cauthor=true&cauthor_uid=26429318 PubMed]
*[http://immunologie.charite.de/ Institute for Medical Immunology]
*[https://cfc.charite.de/ Charité Fatigue Centrum]

==See also==
*[[Wirth-Scheibenbogen hypothesis]]
*[[Invest in ME International ME Conference]]
*[[EUROMENE]]
*[[Charité Berlin]]
*[[Solve ME/CFS Initiative]]

==Learn more==
*[https://solvecfs.org/carmen-scheibenbogen/ Carmen Schiebenbogen] - Solve ME/CFS Initiative
*[https://solvecfs.org/carmen-scheibenbogen-2/ Carmen Schiebenbogen page 2] - Solve ME/CFS Initiative
*[http://www.euromene.eu/workinggroups/Biosketch2016Scheibenbogen.pdf Curriculum Vitae for EUROMENE]

==References==
{{reflist}}

[[Category:Researchers]]
[[Category:Germany researchers]]
[[Category:Clinicians]]
[[Category:German clinicians]]